JACOBS LEVY EQUITY MANAGEMENT, INC
Position in MYGN — Myriad Genetics Inc
CIK 884414
FLORHAM PARK, NJ
Position in MYGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,800,619
+$1,402,405 QoQ
Shares Held
1,891,527
-9.4% QoQ
Ownership
1.98%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#13
of 197 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 73%
Shared 0%
None 27%
Common Shares in MYGN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $104,115,596 across 9 Diagnostics & Research names. MYGN ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
|
995,669 | $28,376,566 | |
| 2 | NTRA |
Natera, Inc.
|
94,577 | $25,672,926 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
|
782,116 | $16,049,020 | |
| 4 | DHR |
Danaher Corp /De/
|
68,743 | $13,094,166 | |
| 5 | MYGN |
Myriad Genetics Inc
This page
|
1,891,527 | $10,800,619 | |
| 6 | GH |
Guardant Health, Inc.
|
33,424 | $5,014,602 | |
| 7 | GRAL |
GRAIL, Inc.
|
55,822 | $3,810,967 | |
| 8 | WGS |
GeneDx Holdings Corp.
|
14,281 | $980,390 |
All Filings in MYGN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,800,619 | 1,891,527 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $9,398,214 | 2,088,492 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $13,962,824 | 2,270,378 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $17,662,253 | 2,442,912 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $5,047,192 | 950,507 | Shares | Sole | 2025-08-14 | |
| 2020-12-31 | $1,243,967 | 62,922 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $10,099,336 | 774,489 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,467,089 | 129,373 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||